Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Kruse-Jarres R, Johnsen JM. How I treat type 2B von Willebrand disease. Blood . 2018;131(12):1292-1300.

Blood (2018) 131 (20): 2272.

https://doi.org/10.1182/blood-2018-04-844357

Published: 2018

Journal Articles

How I treat type 2B von Willebrand disease

Rebecca Kruse-Jarres, Jill M. Johnsen

Blood (2018) 131 (12): 1292–1300.

https://doi.org/10.1182/blood-2017-06-742692

Published: 2018

Journal Articles

Von Willebrand Factor A1 Domain Binds to Clusters II and IV of Low-Density Lipoprotein Receptor-Related Protein 1

Gabriela Uceda Cortez, PhD, Svetlana A Shestopal, PhD, James H Kurasawa, MS, Timothy K Lee, PhD, Andrey G Sarafanov, PhD

Blood (2017) 130 (Supplement 1): 3660.

https://doi.org/10.1182/blood.V130.Suppl_1.3660.3660

Published: 2017

Journal Articles

A Quantitative Assay of In Vivo Cleavage of Von Willebrand Factor By ADAMTS13 Reveals Excessive Cleavage in Type 2B Von Willebrand Disease and Diminished Cleavage in Thrombotic Thrombocytopenic Purpura

Xiaoyun Fu, PhD, Mallory N. Pahl, Yi Wang, PhD, Barbara A. Konkle, MD, Junmei Chen, PhD, Jose A Lopez, MD

Blood (2016) 128 (22): 2532.

https://doi.org/10.1182/blood.V128.22.2532.2532

Published: 2016

Journal Articles

First Case of Platelet-Type Von Willebrand Disease (PT-VWD) Associated with Type 2B Von Willebrand Disease (2B VWD)

Marie Dreyfus, Celine Desconclois, Corinne Guitton, Marie-Jeanne Baas, Helene Mandard, Pierre Boisseau, Jenny Goudemand, MD, PhD, Claudine Caron, Nathalie Itzhar, Agnes Veyradier, Francois Lanza, PhD, MD, Edith Fressinaud

Blood (2011) 118 (21): 5313.

https://doi.org/10.1182/blood.V118.21.5313.5313

Published: 2011

Journal Articles

Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients,

Petra Jilma-Stohlawetz, MD, Paul Knoebl, MD, Ingrid Pabinger, MD, James Gilbert, MD, Robert G. Schaub, PhD, Bernd Jilma, MD

Blood (2011) 118 (21): 3377.

https://doi.org/10.1182/blood.V118.21.3377.3377

Published: 2011

Journal Articles

A Modified Model of Type 2B von Willebrand Disease: Taking ADAMTS13-Mediated Cleavage out of the Equation

Mia Golder, Cynthia M. Pruss, PhD, Kate Sponagle, Carol Hegadorn, Erin Burnett, Andrea Bryant, David Lillicrap, MD

Blood (2010) 116 (21): 23.

https://doi.org/10.1182/blood.V116.21.23.23

Published: 2010

Journal Articles

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions

Mia Golder, Cynthia M. Pruss, Carol Hegadorn, Jeffrey Mewburn, Kimberly Laverty, Kate Sponagle, David Lillicrap

Blood (2010) 115 (23): 4862–4869.

https://doi.org/10.1182/blood-2009-11-253120

Published: 2010

Journal Articles

Active Von Willebrand Factor (VWF) in Plasma of Sickle Cell Patients Is An Indicator of Disease Severity.

Junmei Chen, PhD, William Hobbs, MD, PhD, Jennie Le, Peter J Lenting, PhD, Philip G De Groot, PhD, Jose A. Lopez, MD

Blood (2009) 114 (22): 2552.

https://doi.org/10.1182/blood.V114.22.2552.2552

Published: 2009

Journal Articles

The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation

Shannon C. Jackson, Gary D. Sinclair, Stephanie Cloutier, Zhaoxia Duan, Margaret L. Rand, Man-Chiu Poon

Blood (2009) 113 (14): 3348–3351.

https://doi.org/10.1182/blood-2008-06-165233

Published: 2009

Journal Articles

At least Type VWD2B is a discrete variant of VWD, isn't it?

Robert R. Montgomery

Blood (2009) 113 (3): 501.

https://doi.org/10.1182/blood-2008-11-184531

Published: 2009

Journal Articles

Active Von Willebrand Factor in Plasma of Sickle Cell Patients Is An Indicator for Severity of Sickle Cell Anemia

Junmei Chen, PhD, William Hobbs, MD, PhD, Jennie Le, Peter J Lenting, PhD, Jose A Lopez, MD

Blood (2008) 112 (11): 5445.

https://doi.org/10.1182/blood.V112.11.5445.5445

Published: 2008

Journal Articles

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Luciano Baronciani, PhD, Flora Peyvandi, MD, Margherita Punzo, PhD, Maria T. Canciani, PhD, Enrico Di Stasio, MD, Augusto B. Federici, MD, Pier M. Mannucci, MD, Raimondo De Cristofaro, MD

Blood (2008) 112 (11): 3384.

https://doi.org/10.1182/blood.V112.11.3384.3384

Published: 2008

Journal Articles

Sliding-Rebinding Mechanism Governs Glycoprotein Ib/von Willebrand Factor Catch Bonds.

Jizhong Lou, PhD, Cheng Zhu, Ph.D.

Blood (2007) 110 (11): 3723.

https://doi.org/10.1182/blood.V110.11.3723.3723

Published: 2007

Journal Articles

Glycoprotein Ibα Forms Catch Bonds with von Willebrand Factor A1 Domain but Not with Mutant A1 Domains Exhibiting Properties of Type 2B von Willebrand Disease.

Tao Wu, Tadayuki Yago, Jun Yang, Jonathan Miner, Leslie Coburn, Jose A. Lopez, Miguel A. Cruz, Larry V. McIntire, Rodger P. McEver, Cheng Zhu

Blood (2007) 110 (11): 293.

https://doi.org/10.1182/blood.V110.11.293.293

Published: 2007

Journal Articles

Type 2B “Malmo/New York” Is Not So Rare among Italian Patients with von Willebrand Disease: The Role of P1266L/Q Mutations of the von Willebrand Factor Gene in Seven Cases.

Luciano Baronciani, PhD, Silvia La Marca, PhD, Giancarlo Castaman, MD, Margherita Punzo, PhD, Rosanna Garavaglia, MD, Valentina Rubini, PhD, Giovanna Cozzi, PhD, Maria T. Canciani, PhD, Augusto B. Federici, MD

Blood (2007) 110 (11): 712.

https://doi.org/10.1182/blood.V110.11.712.712

Published: 2007

Journal Articles

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Augusto B. Federici, MD, Luciano Baronciani, PhD, Maria T. Canciani, PhD, Barbara Moroni, PhD, Carlo Balduini, MD, Pier M. Mannucci, MD, Peter J. Lenting, PhD, Philip G. de Groot, PhD

Blood (2006) 108 (11): 1011.

https://doi.org/10.1182/blood.V108.11.1011.1011

Published: 2006

Journal Articles

Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia

Paquita Nurden, Najet Debili, William Vainchenker, Regis Bobe, Raymonde Bredoux, Elisabeth Corvazier, Robert Combrie, Edith Fressinaud, Dominique Meyer, Alan T. Nurden, Jocelyne Enouf

Blood (2006) 108 (8): 2587–2595.

https://doi.org/10.1182/blood-2006-03-009449

Published: 2006

Includes: Supplemental data

Journal Articles

Impaired megakaryocytopoiesis in type 2B von Willebrand disease

Augusto B. Federici

Blood (2006) 108 (8): 2498–2499.

https://doi.org/10.1182/blood-2006-08-037705

Published: 2006

Journal Articles

Severe Thrombocytopenia with Impaired Megakaryocytopoiesis in a Family with von Willebrand Disease Type 2B.

Paquita Nurden, MD, PhD, Najet Debili, PhD, William Vainchenker, MD, PhD, Jean-Max Pasquet, PhD, Regis Bobe, PhD, Raymonde Bredoux, PhD, Alan T. Nurden, PhD, Jocelyne Enouf, PhD

Blood (2005) 106 (11): 733.

https://doi.org/10.1182/blood.V106.11.733.733

Published: 2005

NARROW

Kruse-Jarres R, Johnsen JM. How I treat type 2B von Willebrand disease. Blood . 2018;131(12):1292-1300.

How I treat type 2B von Willebrand disease

Von Willebrand Factor A1 Domain Binds to Clusters II and IV of Low-Density Lipoprotein Receptor-Related Protein 1

A Quantitative Assay of In Vivo Cleavage of Von Willebrand Factor By ADAMTS13 Reveals Excessive Cleavage in Type 2B Von Willebrand Disease and Diminished Cleavage in Thrombotic Thrombocytopenic Purpura

First Case of Platelet-Type Von Willebrand Disease (PT-VWD) Associated with Type 2B Von Willebrand Disease (2B VWD)

Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients,

A Modified Model of Type 2B von Willebrand Disease: Taking ADAMTS13-Mediated Cleavage out of the Equation

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions

Active Von Willebrand Factor (VWF) in Plasma of Sickle Cell Patients Is An Indicator of Disease Severity.

The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation

At least Type VWD2B is a discrete variant of VWD, isn't it?

Active Von Willebrand Factor in Plasma of Sickle Cell Patients Is An Indicator for Severity of Sickle Cell Anemia

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Sliding-Rebinding Mechanism Governs Glycoprotein Ib/von Willebrand Factor Catch Bonds.

Glycoprotein Ibα Forms Catch Bonds with von Willebrand Factor A1 Domain but Not with Mutant A1 Domains Exhibiting Properties of Type 2B von Willebrand Disease.

Type 2B “Malmo/New York” Is Not So Rare among Italian Patients with von Willebrand Disease: The Role of P1266L/Q Mutations of the von Willebrand Factor Gene in Seven Cases.

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia

Impaired megakaryocytopoiesis in type 2B von Willebrand disease

Severe Thrombocytopenia with Impaired Megakaryocytopoiesis in a Family with von Willebrand Disease Type 2B.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only